EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Gene therapy for organic acidemias: Lessons learned from methylmalonic and propionic acidemia

Randy J Chandler iD, Charles P Venditti iD

Journal of Inherited Metabolic Disease · 2024-01 · 47 (1) · 63-79

DOI: 10.1002/jimd.12665 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 07.08.2023. Verfasst von Randy J Chandler und 1 weiteren Autor:innen. Beteiligte Einrichtung: National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Propionic Acidemia, Amino Acid Metabolism, Inborn Errors, Liver Transplantation. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: NHGRI NIH HHS, National Human Genome Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Organic acidemias (OA) are a group of rare autosomal recessive disorders of intermediary metabolism that result in a systemic elevation of organic acid. Despite optimal dietary and cofactor therapy, OA patients still suffer from potentially lethal metabolic instability and experience long‐term multisystemic complications. Severely affected patients can benefit from elective liver transplantation, which restores hepatic enzymatic activity, improves metabolic stability, and provides the theoretical basis for the pursuit of gene therapy as a new treatment for patients. Because of the poor outcomes reported in those with OA, especially methylmalonic and propionic acidemia, multiple gene therapy approaches have been explored in relevant animal models. Here, we review the results of gene therapy experiments performed using MMA and PA mouse models to illustrate experimental paradigms that could be applicable for all forms of OA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Propionic AcidemiaAmino Acid Metabolism, Inborn ErrorsLiver TransplantationAnimalsMiceHumansGenetic TherapyDisease Models, AnimalMethylmalonic Acid

Stichwörter der Autor:innen

AAVCRISPRMMAPAadeno-associated virusgene therapygenome editinghomologous recombinationmRNA therapymethylmalonic acidemiamouse modelsorganic acidemiapropionic acidemia

Substanzen

Methylmalonic Acid

Autor:innen und Institutionen

  • National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.

ORCID-Profile: Randy J Chandler, Charles P Venditti

Förderung

  • NHGRI NIH HHS
  • National Human Genome Research Institute

Zitieren

APA

Chandler, R. J., & Venditti, C. P. (2024). Gene therapy for organic acidemias: Lessons learned from methylmalonic and propionic acidemia. Journal of Inherited Metabolic Disease, 47(1), 63-79. https://doi.org/10.1002/jimd.12665

Vancouver

Chandler RJ, Venditti CP. Gene therapy for organic acidemias: Lessons learned from methylmalonic and propionic acidemia. Journal of Inherited Metabolic Disease. 2024;47(1):63-79. doi:10.1002/jimd.12665

BibTeX
@article{Chandler2024,
  author = {Chandler, Randy J and Venditti, Charles P},
  title = {Gene therapy for organic acidemias: Lessons learned from methylmalonic and propionic acidemia},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2024},
  volume = {47},
  number = {1},
  pages = {63--79},
  doi = {10.1002/jimd.12665}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche